Cincinnati Children s Hospital Medical Center
Tracked across 3 events · 18 articles · First seen Jul 10, 2026 · Last active Aug 25, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Led the study and holds patent rights; positive preclinical results enhance its research reputation and potential for future licensing.
Jul 10, 2026 · 6 articles
Business
Impact: Cincinnati Children's becomes a QTC for ZEVASKYN, offering cutting-edge gene therapy to its RDEB patients.
Jul 21, 2026 · 6 articles
Business
Impact: Cincinnati Children's participated as an investor in the Series E-2 round, demonstrating support for the development of zelpultide alfa. Its involvement adds credibility and financial backing to the company.
Aug 25, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Cincinnati Children s Hospital Medical Center live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard